gibberellic acid has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Qing, C; Zeng, X; Zhang, H; Zhang, Y; Zhao, H | 1 |
1 other study(ies) available for gibberellic acid and Angiogenesis, Pathologic
Article | Year |
---|---|
Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemotaxis; Dose-Response Relationship, Drug; Gibberellins; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Lethal Dose 50; Lung Neoplasms; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Neovascularization, Physiologic; Thalidomide; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |